throbber
Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 1 of 25
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`
`
`
`PHILIPS NORTH AMERICA LLC,
`
`
`Plaintiff,
`
`
`
`
`Civil Action No. 1:19-cv-11586-FDS
`
`
`
`
`
`
`
`
`v.
`
`FITBIT, INC.,
`
`
`
`
`
`
`Defendant.
`
`DEFENDANT FITBIT INC.’S MEMORANDUM OF LAW IN SUPPORT OF ITS
`MOTION TO COMPEL THE PRODUCTION OF
`CERTAIN OF MR. ARIE TOL’S EMAIL COMMUNICATIONS
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 2 of 25
`
`
`
`TABLE OF CONTENTS
`
`Page
`
`INTRODUCTION ...........................................................................................................................1
`
`FACTUAL BACKGROUND & DISCOVERY SOUGHT .............................................................2
`
`LEGAL STANDARDS ...................................................................................................................5
`
`ARGUMENT ...................................................................................................................................6
`
`I.
`
`A PATENT AGENT’S ADVICE THAT DOES NOT PERTAIN TO MATTERS
`BEFORE A PATENT OFFICE IS NOT PROTECTED BY ATTORNEY-
`CLIENT PRIVILEGE. .........................................................................................................6
`
`1.
`
`2.
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under U.S. Law. .......................7
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under Dutch Law. ....................9
`
`II.
`
`III.
`
`COMMUNICATIONS CONVEYING PRIMARILY BUSINESS ADVICE ARE
`NOT ATTORNEY-CLIENT PRIVILEGED OR WORK PRODUCT
`PROTECTED. ...................................................................................................................12
`
`THE REQUESTED COMMUNICATIONS ARE NOT PROTECTED UNDER
`THE WORK PRODUCT DOCTRINE. .............................................................................15
`
`CONCLUSION ..............................................................................................................................18
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`i
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 3 of 25
`
`
`
`TABLE OF AUTHORITIES
`
`CASES
`
`Page(s)
`
`Anwar v. Fairfield Greenwich Ltd.,
`982 F. Supp. 2d 260 (S.D.N.Y. 2013)....................................................................... 6, 8, 11
`
`Atchison Casting Corp. v. Marsh, Inc.,
`216 F.R.D. 225 (D. Mass. 2003) ......................................................................................... 5
`
`Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc.,
`No. 95 CIV. 8833 (RPP), 1998 WL 158958 (S.D.N.Y. Apr. 2, 1998) ............................. 12
`
`Columbia Data Prod., Inc. v. Autonomy Corp.,
`No. CIV.A. 11-12077-NMG, 2012 WL 6212898 (D. Mass. Dec. 12, 2012) ................... 16
`
`E.I. du Pont de Nemours & Co. v. MacDermid, Inc.,
`No. CIV. A. 06-3383 MLC, 2009 WL 3048421 (D.N.J. Sept. 17, 2009) .......................... 9
`
`Gucci Am., Inc. v. Guess?, Inc.,
`271 F.R.D. 58 (S.D.N.Y. 2010) .......................................................................................... 8
`
`Hickman v. Taylor,
`329 U.S. 495 (1947) ............................................................................................................ 5
`
`In re Google Inc.,
`462 F. App’x 975 (Fed. Cir. 2012) ................................................................................... 12
`
`In re Grand Jury Subpoena,
`273 F. Supp. 3d 296 (D. Mass. 2017) ................................................................................. 6
`
`In re IPCom GmbH & Co., KG,
`428 F. App'x 984 (Fed. Cir. 2011) ................................................................................ 9, 10
`
`In re Queen’s University at Kingston,
`820 F.3d 1287 (Fed. Cir. 2016)................................................................................... 6, 7, 8
`
`In re Rivastigimine Pat. Litig.,
`239 F.R.D. 351 (S.D.N.Y. 2006) ...................................................................................... 11
`
`Intell. Ventures I, LLC v. Lenovo Grp. Ltd.,
`No. 16-CV-10860-PBS, 2019 WL 9096048 (D. Mass. Dec. 6, 2019) ..... 12, 14, 15, 16, 17
`
`Massachusetts Eye and Ear Infirmary v. QLT Phototherapeutics, Inc.,
`No. 00-CV-0783 (JLT), 2001 WL 1180694 (D. Mass. Sept. 25, 2001) ........................... 16
`
`Micronics Filtration Holdings, Inc. v. Miller,
`No. 18-CV-303-JL, 2019 WL 9104172 (D.N.H. Nov. 5, 2019) ....................................... 18
`
`
`
`ii
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 4 of 25
`
`
`
`Organon, Inc. v. Mylan Pharms., Inc.,
`303 F.Supp.2d 546 (D. N.J. 2004) ...................................................................................... 9
`
`PersonalWeb Techs., LLC v. Google Inc.,
`No. 13-C-01317-EJD, 2014 WL 4088201 (N.D. Cal. Aug. 19, 2014)..…………………17
`
`
`SanDisk Corp. v. Round Rock Rsch. LLC,
`No. 11-CV-05243-RS (JSC), 2014 WL 691565 (N.D. Cal. Feb. 21, 2014) ............... 15, 18
`
`Tulip Computers International B.V. v. Dell Computer Corp.,
`2002 WL 31556497 (Nov. 15, 2002 D. Del.) ..................................................................... 9
`
`U.S. v. McLellan,
`No. 16-CR-10094-LTS, 2018 WL 9439896 (D. Mass. Jan. 19, 2018) ............................... 5
`
`U.S. v. Textron Inc. & Subsidiaries,
`577 F.3d 21 (1st Cir. 2009) ......................................................................................... 16, 18
`
`VLT Corp. v. Unitride Corp.,
`194 F.R.D. 8 (D. Mass. 2000) ......................................................................................... 5, 6
`
`OTHER AUTHORITIES
`
`Bruil v. Tital International,
`Rechtbank Zutphen [District Court of Zutphen], 1 May 1988,
`ECLI:NL:RBZUT:1988:AB8996 (Neth.) ..................................................................... 9, 10
`
`Rijkswet van 15 december 1994 [Dutch Patent Act], Articles 23, 80, and 82, available at
`https://wetten.overheid.nl/BWBR0007118/2020-04-01#Hoofdstuk6_Artikel82 ....... 10, 11
`
`The EU Single Market Regulated Professions Database: Octrooigemachtigde
`(Netherlands), available at https://ec.europa.eu/growth/tools-
`databases/regprof/index.cfm?action=regprof&id_regprof=834&tab=general ................. 11
`
`RULES
`
`Fed. R. Civ. P. 26(b)(1)................................................................................................................... 5
`
`Fed. R. Civ. P. 26(b)(3)................................................................................................................. 16
`
`Fed. R. Civ. P. 26(b)(3)(A) ........................................................................................................... 16
`
`Fed. R. Evid. 501 ............................................................................................................................ 5
`
`
`
`
`
`iii
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 5 of 25
`
`
`
`INTRODUCTION
`
`Defendant Fitbit, Inc. (“Fitbit”) moves to compel Plaintiff Philips North America LLC
`
`(“Philips”) to produce email communications Philips improperly withheld for privilege.
`
`Specifically, Fitbit seeks to compel production of emails of Mr. Arie Tol, a Dutch patent agent
`
`employed by Philips’s parent, Koninklijke Philips N.V., in its intellectual property licensing
`
`division, Philips Intellectual Property and Standards (“Philips IP&S”). Mr. Tol has first-hand
`
`knowledge regarding Philips’s licensing practices and policies, both generally and as they relate
`
`to the litigation against Fitbit—matters relevant to Fitbit’s defenses. Nonetheless, both during Mr.
`
`Tol’s deposition and in response to Fitbit’s subsequent requests for Mr. Tol’s relevant emails,
`
`Philips prevented Fitbit from obtaining this relevant discovery by improperly invoking attorney-
`
`client privilege and work product protection. Accordingly, Fitbit moves to compel certain entries
`
`on Mr. Tol’s email privilege log (attached as Exhibit A (April 16 Privilege Log)) for three reasons.
`
`First, Philips’s invocation of attorney-client privilege for communications exclusively
`
`between Dutch patent agents and other non-attorney employees who were not acting at the
`
`direction and control of a licensed attorney, and related to matters other than representation before
`
`a patent office, has no basis in U.S. or Dutch law. Patent agent privilege extends only to matters
`
`before a patent office, such as patent prosecution. As such, Philips’s claims of attorney-client
`
`privilege over communications between patent agents related to the post-issuance assertion of
`
`patents it acquired from third-parties and did not prosecute, is improper under U.S. law.
`
`Additionally, to the extent Dutch law applies—and Fitbit contends that it does not—these
`
`communications are not privileged because, like the U.S., the Netherlands does not recognize a
`
`patent agent privilege for matters other than proceedings before the Netherlands Patent Office.
`
`Second, regardless of the communicants, Philips improperly invokes attorney-client
`
`privilege for communications that appear to deal primarily with business—rather than legal—
`
`1
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 6 of 25
`
`
`
`advice, particularly communications related to Philips’s licensing business and attempts to license
`
`Fitbit or license the asserted patents. Communications dealing predominantly with business advice
`
`or negotiations do not fall within the limited purview of attorney-client privilege.
`
`Third, Philips invokes work product protection for communications as early as June
`
`2015—four years before Philips filed its complaint in this case and well before the parties even
`
`began, much less ended, amicable business discussions negotiating a potential license. Philips did
`
`not have a reasonable expectation of litigation in 2015 and has not identified any other plausible
`
`pre-filing date by which it formed a reasonable anticipation of litigation.
`
`For these three reasons, Mr. Tol’s emails are not protected from discovery by attorney-
`
`client privilege or as work product. Accordingly, Fitbit moves to compel the production of Mr.
`
`Tol’s emails reflected at Entry Nos. 3-4; 19-21; 24; 26; 28; 30-31; 35-37; 42-43; 46-48; 58-66; 70-
`
`73; 79; 82; 144; 155-156; 162-163; 208-209; 244-248; 260-270; 299-301; 349-350; 364; 382-383;
`
`392; 394-395; 408; 412-431; 433; 437-438; 440-441; 443; 450-451; 458-460; and 463-464 in
`
`Philips’s April 16 log.1 (Ex. A).
`
`FACTUAL BACKGROUND & DISCOVERY SOUGHT
`
`Philips acquired U.S. Patent Nos. 6,013,007 (“the ’007 patent”); 7,088,233 (“the ’233
`
`patent”); and 8,277,377 (“the ’377 patent”) (collectively, the “Patents-in-Suit”) from third-parties
`
`after they were prosecuted and issued. On October 10, 2016, Philips sent a letter to Fitbit stating
`
`that “Philips is willing to discuss with Fitbit the terms and conditions of a non-exclusive,
`
`worldwide license” for a variety of patents, including the currently-asserted patents in this case.
`
`
`1 Philips’s May 28 and June 11 supplemental logs, (Exs. L & M), are not comprehensive; they
`relate to only a subset of the entries identified on the April 16 log. As such, Fitbit identifies the
`entry numbers enumerated on the April 16 log, the most recent complete log served by Philips.
`Because Philips’s privilege logs themselves have been marked confidential in their entirety, entries
`not subject to this motion have been redacted.
`
`
`
`2
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 7 of 25
`
`
`
`(Ex. B (Licensing Letters).) Philips sent similar correspondence to Fitbit on March 23 and April
`
`13, 2017. (Id.) The parties subsequently discussed the possibility of what Philips called “business
`
`discussions” related to a potential license throughout 2017 and 2018. (See Ex. C (2017 email
`
`exchange); Ex. D (2018-2019 email exchange).) Despite these ongoing negotiations, Philips filed
`
`the complaint in this matter on July 22, 2019.2
`
`Philips licenses its intellectual property through its IP&S division, which is authorized to
`
`license patents owned by Philips’s parent, Koninklijke Philips N.V. (See Ex. E (Tol Dep. Tr.) at
`
`12:18-18:7; Ex. B.) Mr. Arie Tol is a registered Dutch patent agent (or “octrooigemachtigden”)
`
`employed by Philips IP&S at its headquarters in Eindhoven, The Netherlands; Mr. Tol’s primary
`
`responsibility is licensing Philips’s patents, not patent prosecution. (See Ex. E at 11:2-12:17.)
`
`While Philips will likely refer to Mr. Tol as a “Dutch Patent Attorney,” Mr. Tol is not a bar-
`
`admitted Dutch attorney-at-law (or “advocaat”). This title instead relates to his status as a patent
`
`agent admitted to practice before the Netherlands Patent Office.
`
`Pursuant to his duties at Philips IP&S, Mr. Tol has first-hand knowledge of Philips’s
`
`licensing practices and policies, including Philips’s attempts to license the Patents-in-Suit to Fitbit
`
`and others. Indeed, Mr. Tol was Philips’s primary representative in licensing discussions with
`
`Fitbit. Nonetheless, Philips omitted Mr. Tol from its original Initial Disclosures and did not amend
`
`its disclosures to include Mr. Tol until January 22, 2021—more than a week after Mr. Tol was
`
`deposed. (See Ex. F (Philips Initial Disclosures); Ex. G (Philips Amended Initial Disclosures).)
`
`Despite Philips’s omission, Fitbit sought discovery into Mr. Tol’s knowledge and
`
`communications regarding Philips’s licensing practices and related topics during Mr. Tol’s
`
`
`2 While Philips filed an infringement action against Fitbit in Germany in December of 2017, it
`continued to pursue commercial discussions with Fitbit in the U.S. through the service of the
`complaint in mid-2019.
`
`
`
`3
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 8 of 25
`
`
`
`January 13, 2021 deposition. However, Mr. Tol refused to testify as to those matters based on an
`
`incorrect instruction from Philips’s counsel that such information is protected by attorney-client
`
`privilege. (See, e.g. Ex. E at 59:3-62:1; Ex. H (January 2021 Letter to Philips).) As Fitbit was
`
`unable to question Mr. Tol about those topics during his original deposition and Philips refused to
`
`make Mr. Tol available for additional questioning (see Ex. I (February 2021 email from Philips)),
`
`Fitbit subsequently requested that Philips search Mr. Tol’s electronically stored information,
`
`including emails, for relevant communications.3
`
`While Philips agreed to search Mr. Tol’s emails and ultimately produced a subset of the
`
`email search hits on March 23, 2021—the last day of fact discovery—it also produced a privilege
`
`log describing more than five-hundred of Mr. Tol’s emails that hit on the search terms, but were
`
`withheld for privilege. Philips’s March 23 log continued to improperly assert attorney-client
`
`privilege and work product protection as to communications that either: (1) occurred between
`
`individuals to whom attorney-client privilege does not apply; (2) deal with subject matter—namely
`
`business advice related to Philips’s commercial licensing practices—that is not privileged; or (3)
`
`occurred well-before Philips could have plausibly formed a reasonable anticipation of litigation
`
`such that work product protection could apply. (See Ex. J (March 23 Privilege Log).)
`
`The parties met and conferred regarding Philips’s March 23 log, after which Philips agreed
`
`to reevaluate the log in light of case law raised by Fitbit, namely that business advice is typically
`
`not privileged. Philips subsequently produced an amended log on April 16, 2021 (see Ex. A),
`
`removing some entries that reflect non-privileged business advice, but retaining many others with
`
`modified descriptions—which previously suggested the communications deal with non-privileged
`
`
`3 Pursuant to the email discovery provisions in the Stipulated Discovery plan, Fitbit requested these
`communications via search terms. (See D.I. 59.)
`4
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 9 of 25
`
`
`
`discussions related to licensing—to instead indicate that the entries reflect legal advice.
`
`The parties subsequently met and conferred about Philips’s amended log, and Philips
`
`agreed to further assess the April 16 amended log and provide additional information
`
`substantiating its bases for asserting privilege. Fitbit also requested that Philips name the employer
`
`of each individual on Philips’s log and specify whether or not each individual is a bar-admitted
`
`attorney-at-law (or “advocaat”). Philips provided that information via email. (See Ex. K.)
`
`On May 28, 2021 and again on June 11, after multiple meet and confers, Philips amended
`
`its April 16 log twice more, each time removing additional entries that it agrees were improperly
`
`withheld as privileged and amending—or, in some instances, completely revising—the
`
`descriptions of others. (See Ex. L (May 28 Log); Ex. M (June 11 Log).) Nonetheless, Philips’s
`
`operative logs retain numerous entries reflecting improperly withheld communications. The
`
`parties have met and conferred regarding these issues on multiple occasions, but are at an impasse.
`
`LEGAL STANDARDS
`
`A party may obtain discovery of “any non-privileged matter that is relevant to any party’s
`
`claim or defense and proportional to the needs of the case….” Fed. R. Civ. P. 26(b)(1). “The
`
`broad scope of the discovery rules reflects a policy that ‘[m]utual knowledge of all the relevant
`
`facts gathered by both parties is essential to proper litigation.’” Atchison Casting Corp. v. Marsh,
`
`Inc., 216 F.R.D. 225, 227 (D. Mass. 2003) (quoting Hickman v. Taylor, 329 U.S. 495, 507 (1947)).
`
`“The common law—as interpreted by the United States courts in the light of reason and
`
`experience—governs a claim of privilege.” Fed. R. Evid. 501. Pursuant to this Rule, U.S. courts
`
`may apply the privilege law of foreign jurisdictions “when those jurisdictions have a strong interest
`
`in the relationship at issue.” VLT Corp. v. Unitride Corp., 194 F.R.D. 8, 14-15 (D. Mass. 2000).
`
`To determine whether U.S. or foreign privilege law applies to a given communication, courts in
`
`the First Circuit apply the “touching base” test. See, e.g., id. at 15-16; U.S. v. McLellan, No. 16-
`5
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 10 of 25
`
`
`
`CR-10094-LTS, 2018 WL 9439896, at *1-2 (D. Mass. Jan. 19, 2018).
`
`“If a communication has nothing to do with the United States
`or…[has] only an incidental connection to this country, the privilege
`issue will be determined by the law of the foreign nation. If,
`however,
`the communication has more
`than an
`incidental
`connection to the United States, the courts will undertake a more
`traditional analysis and defer to the privilege of the nation having
`the most direct and compelling interest in the communication….”
`
`VLT Corp., 194 F.R.D. at 16. “Communications concerning legal proceedings in the United States
`
`or advice regarding United States law are typically governed by United States privilege law, while
`
`communications relating to foreign legal proceedings or foreign law are generally governed by
`
`foreign privilege law.” Anwar v. Fairfield Greenwich Ltd., 982 F. Supp. 2d 260, 263 (S.D.N.Y.
`
`2013) (applying the touching base test to communications with foreign patent agents).
`
`The party asserting attorney-client privilege or work product protection bears the burden
`
`to prove that the withheld documents are, in fact, covered by the claimed privilege or protection.
`
`See, e.g., In re Queen’s Univ. at Kingston, 820 F.3d 1287, 1291 (Fed. Cir. 2016) (attorney-client
`
`privilege); In re Grand Jury Subpoena, 273 F. Supp. 3d 296, 304 (D. Mass. 2017) (work-product).
`
`ARGUMENT
`
`I.
`
`A PATENT AGENT’S ADVICE THAT DOES NOT PERTAIN TO MATTERS
`BEFORE A PATENT OFFICE IS NOT PROTECTED BY ATTORNEY-CLIENT
`PRIVILEGE.
`
`Philips withheld emails between Mr. Tol and other patent agents or non-attorney Philips
`
`employees that do not relate to proceedings before a patent office, and Philips has not indicated
`
`that these communications were made at the direction of or relayed the advice of any attorney.
`
`Such communications are not entitled to patent agent privilege or attorney-client privilege. The
`
`emails corresponding to the following entries on Philips’s April 16 log involve communications
`
`exclusively between Philips’s in-house patent agents and other non-attorney employees: 3-4; 26;
`
`
`
`6
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 11 of 25
`
`
`
`28; 42; 46-48; 58-59; 65-66; 82; 155-156; 208-209; 349-350.4 These emails primarily relate to
`
`the present U.S. litigation and Philips’s pre-suit investigation. As such, they touch base with the
`
`U.S. and are governed by U.S. privilege law.
`
`Because communications related to patent validity or infringement pertain to the Federal
`
`Circuit’s exclusive jurisdiction, the application of privilege to such communications is governed
`
`by Federal Circuit law. See, e.g., In re Queen’s, 820 F.3d at 1301. The scope of privilege for
`
`patent agents not acting under the direction or control of a licensed attorney is limited. Importantly,
`
`“[c]ommunications that are not reasonably necessary and incident to the prosecution of patents
`
`before the Patent Office fall outside the scope of the patent-agent privilege.” Id. at 1301. “For
`
`instance, communications with a patent agent who is offering an opinion on the validity of another
`
`party’s patent in contemplation of litigation or for the sale or purchase of a patent, or on
`
`infringement,” are not per se privileged. Id. at 1301-02.
`
`Because the U.S. does not recognize a privilege for patent agent communications unrelated
`
`to proceedings before a patent office, these emails are not privileged and should be produced.
`
`Moreover, even if these emails touch base with the Netherlands and Dutch privilege law applies,
`
`they still are not privileged because, like the U.S., the Netherlands does not recognize a privilege
`
`for patent agent communications unrelated to patent office proceedings.5
`
`1.
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under U.S. Law.
`
`Philips withheld numerous communications between Mr. Tol and other Dutch patent
`
`agents or non-attorney employees on the basis of attorney-client privilege. As described in
`
`
`4 Philips’s claims of work product protection for these communications is also incorrect, as
`addressed below.
`5 The scope of patent-agent privilege in other jurisdictions is beyond the scope of this brief, and
`Fitbit takes no position on such issues.
`
`
`
`7
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 12 of 25
`
`
`
`Philips’s April 16 and supplemental logs, these communications predominantly relate to Philips’s
`
`purported “pre-suit investigation” of Fitbit,6 or Philips’s “ongoing and threatened litigation with
`
`Fitbit” in the U.S.7 (See, e.g., Ex. A at Entry Nos. 3-4; 246-248.) Thus, these communications
`
`relate to Fitbit’s alleged infringement of U.S. patents arising from conduct within the U.S. and the
`
`present U.S. patent infringement action. Such communications clearly have more than an
`
`“incidental relationship” to the U.S. Indeed, the U.S. has a direct and compelling interest in
`
`ensuring that its intellectual property laws are enforced according to and consistent with the
`
`procedures and policies embedded in federal law. As such, these communications touch base with
`
`the U.S. and are governed by U.S. privilege law. See, e.g., Anwar, 982 F. Supp. 2d at 263; Gucci
`
`Am., Inc. v. Guess?, Inc., 271 F.R.D. 58, 65 (S.D.N.Y. 2010).
`
`Mr. Tol and the other participants on the above-identified communications are either Dutch
`
`patent agents or non-attorney employees—not licensed attorneys. Under U.S. privilege law,
`
`“[c]ommunications that are not reasonably necessary and incident to the prosecution of patents
`
`before the Patent Office fall outside the scope of the patent-agent privilege.” In re Queen’s, 820
`
`F.3d at 1301. Thus, for example, “communications with a patent agent who is offering an opinion
`
`on…the sale or purchase of a patent, or on infringement,” are not privileged. Id. at 1301-02.
`
`Consequently, Dutch patent agent communications relating to licensing, pre-suit investigations of
`
`infringement, or “ongoing or threatened” litigation do not fall within the limited scope of the
`
`patent-agent privilege. Nor is there any indication that privilege might apply because these
`
`
`6 As explained below, Fitbit believes that many of these communications in fact relate to Philips’s
`efforts and negotiations to license its patents to Fitbit in the U.S., rather than investigation or
`preparation for litigation.
`7 Entry Nos. 42-43, 46-47, and 155-156 purportedly relate to amendments to a patent purchase
`agreement between Philips and Roger Quy, a U.S. citizen and the named inventor and previous
`owner of the ’377 Patent. Because these communications relate to a transaction with a party in the
`U.S. for rights in a U.S. patent, these communications also touch base with the U.S.
`8
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 13 of 25
`
`
`
`individuals were acting under the direction and supervision of licensed attorneys in the course of
`
`these communications. See, e.g., E.I. du Pont de Nemours & Co. v. MacDermid, Inc., No. CIV.
`
`A. 06-3383 MLC, 2009 WL 3048421, at *4 (D.N.J. Sept. 17, 2009) (finding that communications
`
`made to patentee’s in-house patent agent were not privileged because the agent “was not acting
`
`under the authority and control” of a licensed attorney). Indeed, in the course of providing its June
`
`11 supplemental privilege log, Philips specifically noted that other entries contained the advice of
`
`attorneys not directly party to the communication (see e.g., Ex. M at Entry Nos. 6-8), but made no
`
`such representation as to these entries, further suggesting that licensed attorneys were not involved
`
`in any way. Accordingly, Philips cannot withhold these communications on the basis of attorney-
`
`client privilege.
`
`2.
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under Dutch Law.
`
`While Fitbit believes that U.S. law applies to the aforementioned patent agent
`
`communications under the touching base test, applying Dutch law does not change the outcome.8
`
`Like the U.S., the Netherlands does not recognize a privilege for patent agent
`
`communications concerning topics other than proceedings before a patent office. See Bruil v. Tital
`
`International, Rechtbank Zutphen
`
`[District Court of Zutphen], 1 May 1988,
`
`ECLI:NL:RBZUT:1988:AB8996 (Neth.)9; Tulip Computers International B.V. v. Dell Computer
`
`Corp., 2002 WL 31556497, at *1 (Nov. 15, 2002 D. Del.); Organon, Inc. v. Mylan Pharms., Inc.,
`
`303 F.Supp.2d 546, 547 (D. N.J. 2004) (interpreting Bruil to hold “that a [Dutch] patent agent may
`
`not assert the privilege of non-disclosure for acts beyond the scope of his specific duties in
`
`
`8 Because the choice of law issue is not dispositive, the court may render a decision based purely
`on U.S. law. See, e.g., In re IPCom GmbH & Co., KG, 428 F. App'x 984, 986 (Fed. Cir. 2011).
`9 A translated copy of a summary of this decision is attached as Ex. N. Despite diligent efforts,
`Fitbit was unable to locate a copy of the full decision in this matter.
`9
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 14 of 25
`
`
`
`rendering assistance with respect to patent applications.”). As explained in Bruil v. Tital
`
`International, to Fitbit’s knowledge the only Dutch case law opining directly on the matter, the
`
`scope of a Dutch patent agent’s privilege is limited to those specific activities for which s/he is
`
`licensed—namely, “rendering assistance with the patent application.” (Ex. N at 1.) And while
`
`subsequent amendments to the Dutch Patent Act (“DPA”) have acknowledged that Dutch patent
`
`agents may more generally assist with acts and proceedings before the Netherlands Patent Office
`
`and limited proceedings before the District Court of the Hague, the scope of a patent agent’s
`
`licensure remains limited to those specific activities and, in particular, does not extend to the
`
`general context of litigation, which requires admission to the Netherlands bar as an advocaat. See
`
`Rijkswet van 15 December 1994
`
`[Dutch Patent Act], Article 82, available at
`
`https://wetten.overheid.nl/BWBR0007118/2020-04-01#Hoofdstuk6_Artikel82.10
`
`During the parties’ meet and confers, Philips put forth a number of arguments purportedly
`
`showing that, under Dutch law, a Dutch patent agent’s communications regarding matters not
`
`before a patent office are nonetheless privileged. None are convincing, particularly since U.S. law
`
`applies to the relevant communications under the touching base test.
`
`First, Philips argued that such communications are de facto protected from discovery
`
`because “Dutch courts do not provide for automatic discovery” and consequently “Dutch law
`
`would protect these materials from discovery, regardless of whether a specific privilege applies.”
`
`(See Ex. O (May 28 email from Philips).) Philips “cannot use [Dutch] discovery laws to shield
`
`itself from producing documents that can be used to attack the validity or enforceability of its
`
`patents” in U.S. litigation. In re IPCom, 428 F. App’x at 986.
`
`Second, Philips argued that the Dutch Code of Civil Procedure (“DCCP”) provides only
`
`
`10 All relevant sections of the DPA referenced herein are also attached as Exhibit S.
`10
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 15 of 25
`
`
`
`“for a narrow and limited means to seek a court order demanding the production of documents”
`
`and that “internal confidential communications of Philips’s Dutch Patent Attorneys would never
`
`qualify for such relief.” (Ex. O.) But this argument has already been rejected by U.S. courts. See,
`
`e.g., Anwar, 982 F. Supp. 2d at 266-68 (finding that “Dutch law allows wide-ranging document
`
`disclosure” and requiring the production of communications of defendant’s in-house lawyer).
`
`Third, Philips argues that the DCCP and DPA require patent agents to maintain the
`
`confidentiality of information disclosed to them in the course of their profession as patent agents.11
`
`(See Ex. O.) First, such provisions “create at most a professional secrecy obligation for patent
`
`agents, not an absolute evidentiary privilege comparable to U.S. attorney-client privilege.” In re
`
`Rivastigimine Pat. Litig., 239 F.R.D. 351, 357 (S.D.N.Y. 2006) (finding the comparable Swiss
`
`statutes did not protect communications of Swiss patent agents from discovery). Second, such
`
`provisions do not apply to the communications at issue because the subject matter of those
`
`communications—U.S. litigation—does not fall within the professional capacity of a Dutch patent
`
`agent as such. See The EU Single Market Regulated Professions Database: Octrooigemachtigde
`
`(Netherlands) (explaining that patent agents “take[] care of the procedures for the acquisition and
`
`maintenance of protection at the Netherland Patent Office” and that “[t]he exclusive service for
`
`patent attorneys is limited to represent the client for the NL patent office with the exception of
`
`services that are of administrative nature such as filing translations and the payment of annual
`
`fees.”),
`
`available
`
`at
`
`https://ec.europa.eu/growth/toolsdatabases/regprof/index.cfm?action=regprof&id_regprof=834&
`
`
`11 For example, Article 23b of the DPA provides that “a patent attorney or a person working under
`his responsibility is obliged to observe secrecy with regard to all information of which he becomes
`aware by virtue of his activities as such.” Dutch Patent Act, Article 23b, available at
`https://wetten.overheid.nl/BWBR0007118/2010-10-10#Hoofdstuk2_Paragraaf1a_Artikel23a.
`11
`
`
`
`

`

`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 16 of 25
`
`
`
`tab=general.
`
`In sum, to the extent Philips’s Dutch patent agents engage in activities beyond
`
`representation before a patent office, they do so outside the scope of their capacity as a patent agent
`
`and any attendant privilege under Dutch law. While it may be true that in practice, Philips’s patent
`
`agents’ responsibilities are broader than representation before the patent office, tha

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket